TLSI
TriSalus Life Sciences Inc.
NASDAQ: TLSI · HEALTHCARE · MEDICAL DEVICES
$4.39
+1.62% today
Updated 2026-05-01
Market cap
$275.75M
P/E ratio
—
P/S ratio
6.11x
EPS (TTM)
$-1.84
Dividend yield
—
52W range
$3 – $8
Volume
0.2M
TriSalus Life Sciences Inc. (TLSI) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-677599.00 | $-22.70M | $-32.31M | $-50.58M | $-40.84M | $-18.01M |
| Capital expenditures | $545000.00 | $1.26M | $786000.00 | $588000.00 | $345000.00 | $918000.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | $22000.00 | $109000.00 | $368000.00 | $1.40M | $5.44M | $9.13M |
| Free cash flow | $-1.22M | $-23.95M | $-33.10M | $-51.17M | $-41.19M | $-18.93M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |